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ABSTRACT 
Background: Respiratory syncytial virus (RSV) can infect myeloid dendritic cells 
(mDCs) and regulate their function in the development of allergy. It has been widely 
reported that plasmacytoid DCs (pDCs) play a critical role in anti-viral innate immunity. 
In contrast, not much is known about the role of pDCs in the interaction between allergy 
and viral infection. The purpose of the present study was to investigate the effect of 
RSV infection on pDC function in the regulation of allergic airway inflammation in a 
murine model of Dermatophagoides farinae (Derf)-sensitized allergic asthma. 
Methods: Splenic pDCs isolated from Derf-sensitized donor mice were infected with 
live RSV ex vivo. Subsequently, these pDCs were inoculated into the airways of 
Derf-sensitized recipient mice. Lung pathology, lung tissue cytokine profiles, the 
number of regulatory T cells (Treg) and mDCs, as well as the effects of IL-10 
neutralization in the lung tissue of recipient mice were determined. 
Results: Intranasal inoculation of Derf-sensitized pDCs significantly inhibited the 
development of allergic airway inflammation and both Th1 and Th2 immunity. Live 
RSV infection of these pDCs prior to inoculation interfered with their inhibitory effects 
through decreasing Treg and IL-10 and increasing mDCs. 
Conclusions: In asthmatic airways, pDCs mediate tolerance to inhaled allergens 
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through the regulation of Treg, IL-10 and mDCs. RSV infection of pDCs potentially 
inhibits their immunotolerogenic effects and thus exacerbates allergic airway 
inflammation. 
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Introduction 
Bronchial asthma is a chronic airway inflammatory disease characterized by 
reversible airflow obstruction and hyper-responsiveness to non-specific stimuli, and 
represents a type-2 helper T (Th2) cell-mediated immunologic lung disease.[1] The 
most common trigger of acute exacerbation of asthma is viral infection in both children 
and adults.[2,3] Although the exact underlying mechanism of virus-induced asthma 
exacerbation remains unknown, it is likely that viral infection exacerbates 
Th2-dominant allergic airway inflammation.[4] Respiratory syncytial virus (RSV) is a 
representative lower respiratory tract pathogen of childhood and may exacerbate 
asthma.[5,6] According to the so-called hygiene hypothesis[7], repeated viral infections 
in early childhood inhibit the development of allergic disease[8], whereas rival 
hypotheses propose that viral respiratory infections and mite allergen exposure promote 
the development of asthma.[9] An infant history of RSV bronchiolitis can result in the 
development of asthma in later childhood.[10-12] Therefore, the interaction between 
viral infections and allergic asthma remains unclear. 
Dendritic cells (DCs) are the most potent antigen-presenting cells (APCs) in 
the airways and are involved in antigen uptake, processing, and presentation of 
antigenic fragments to T cells in the respiratory mucosa.[13,14] Furthermore, DCs 
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determine the type of T cell-mediated immune response (Th1 or Th2) and play a central 
role in initiating both allergy and infection.[15,16] Lung tissue contains a large number 
of DCs. Until recently, the precise lineage of DCs in lung tissue was poorly defined. It is 
now becoming clear that different DC subsets exist with functional specialization. In 
humans and mice, several subtypes of DCs, characterized by surface markers and 
function, have been described. Generally, DCs can be distinguished as either myeloid 
DCs (mDCs) or plasmacytoid DCs (pDCs).[17] Utilizing a murine model of allergic 
asthma and bone marrow-derived mDCs, we previously reported that the in vivo 
transfer of mDCs into airways caused allergic airway inflammation[18], that primary 
RSV infection ameliorated mDC-induced allergic airway inflammation[19] and that 
repeated RSV infection enhanced allergic airway inflammation via differential 
regulation of pulmonary mDC function.[20] It is likely that mDCs are collectively 
important for generating T cell division and priming and that RSV can directly infect 
mDCs to modulate their immunological properties. On the other hand, pDCs possess 
only a modest capacity to activate naïve T cells and constitute an essential component of 
innate immunity by secreting various cytokines and chemokines as well as by 
participating in the activation of natural killer cells.[21-23] pDCs have been 
demonstrated to be specialized in the production of high levels of IFN in response to 
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various viruses both in humans and mice.[24-26] In contrast to their primary role in 
innate immunity, not much is known about the role of pDCs in allergy. It has been 
reported that pDCs have an essential immunoregulatory role in the lung that protects 
against the development of airway inflammation towards harmless antigens in mice.[23] 
To date, there have been few studies that have evaluated the role of pDCs in the 
interaction between respiratory viral infection and allergy. 
The purpose of this study was to investigate the effect of RSV infection on pDC 














Female BALB/c mice, 4–6 weeks of age, free of specific pathogens, were purchased 
from Charles River Laboratories (Yokohama, Japan). They were housed under 
pathogen-free conditions at the Laboratory Animal Center for Biochemical Research, 
Nagasaki University School of Medicine. All experimental procedures were reviewed 
and approved by the Nagasaki University School of Medicine Committee on Animal 
Research. Experiments were repeated at least three times. 
 
Virus 
The human RSV A2 strain was purchased from the American Type Culture Collection 
(ATCC, Rockville, MD), and the virus was propagated by infection of Hep-2 cells 
(ATCC) in a monolayer culture. For preparation of a large stock of the virus, Hep-2 
cells were infected with the ATCC stock virus and the cell supernatant was collected 5 
or 6 days post-infection. The supernatant was centrifuged at 2,000 rpm for 10 min at 4 
C to remove cellular debris. The clear supernatant was collected and stored at 70 C. 
The infectivity of the virus stock (1.0  104 plaque-forming units RSV/mL) was 
adjusted as assessed by a quantitative plaque-forming assay. An aliquot of the viral 
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suspension was inactivated by heating for 30 min at 121 C (heat-inactivated RSV; 
HI-RSV). 
 
Preparation of pDC from mite allergen-sensitized donor mice 
Two groups of donor mice were prepared: Control and Dermatophagoides farinae (D. 
farinae) allergen-sensitized (Df) mice. Control mice were injected twice 
intraperitoneally (i.p.) on days 1 and 14 with phosphate-buffered saline (PBS) and then 
challenged intranasally (i.n.) with 50 L of PBS once a day on days 1416. Df mice 
were immunized twice i.p. on days 1 and 14 with 0.5 mg/mouse of D. farinae allergen 
(LG-5339, Cosmo Bio, Tokyo, Japan) precipitated in aluminum hydroxide and then 
challenged i.n. with 50 g/mL of D. farinae allergen once a day on days 1416. Donor 
mice were sacrificed by cervical dislocation on day 17 followed by dissection of the 
spleen tissue. For splenic pDC isolation, spleen tissues were injected with 500 L of 
Collagenase D (Boehringer-Mannheim, Mannheim, Germany) solution per spleen, the 
tissue was then cut into small pieces and incubated in Collagenase D solution for 30 min 
at 37 C. Splenic cells were mechanically filtered through a 250-m mesh, and further 
purified over a Ficoll (Amersham Biosciences, Uppsala, Sweden) gradient by 
suspending the cells in a 10-mL solution of 1.075 g/mL high density Ficoll and 
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centrifuging at 1,500 rpm for 10 min. Low density cells were collected, resuspended, 
and washed in RPMI-1640 (Gibco, Grand Island, NY, USA) supplemented with 1% 
fetal bovine serum (FBS) and 0.1% penicillin-streptomycin (Gibco) (hereafter referred 
to as cRPMI). Splenic pDCs, isolated from Control (contDC) and Df (DfDC) mice were 
purified by magnetic cell sorting (MACS Technology) using the Plasmacytoid Dendritic 
Cell Isolation kit (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the 
manufacturer’s protocol. Splenic cells were incubated with anti-CD3, anti-CD19, 
anti-CD11b and anti-CD49b antibody-MicroBeads and were passed through a negative 
selection LD column with a MidiMACS magnet. The collected unlabeled cells were 
incubated with anti-CD45R (B220) antibody-MicroBeads and passed through a positive 
selection LS column with a MiniMACS magnet. The viability of the cells was assessed, 
in triplicate, after 48 h by trypan-blue exclusion. The isolated splenic pDCs were sorted 
based on their expression of PDCA-1 and CD11c using specific antibodies (Miltenyi 
Biotec) and a BD FACS CantoII (Becton Dickinson, Oakville, Canada). The pDC 
population was ≥90% pure in three independent experiments. 
 
In vivo transfer of pDCs to mite allergen-sensitized recipient mice 
Purified splenic pDCs from donor mice were washed and resuspended in cRPMI. 
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Isolated contDC or DfDCs were inoculated i.n. at a concentration of 4  105 cells, in a 
volume of 100 L/mouse, into 6-week-old naïve female BALB/c mice on day 1. All 
mice were also immunized i.p. on day 1 with 0.5 mg/mouse of the D. farinae allergen 
precipitated in aluminum hydroxide. Mice were then challenged i.n. with either 50 L 
of PBS (contDC-PBS and DfDC-PBS groups of mice) or with 50 L of 50 g/mL of D. 
farinae allergen (contDC-Df and DfDC-Df groups of mice) once a day on days 14–16. 
In a different set of experiments, DfDC-Df recipient mice were injected i.p. with 500 g 
anti-mouse IL-10R monoclonal antibody (1B1.3a; Becton Dickinson) 
(DfDC-Df-IL-10R group) or isotype control antibody (rat IgG1; BD Biosciences ) on 
day 1 together with the D. farinae allergen precipitated in aluminum hydroxide. 
Bronchoalveolar lavage (BAL) was conducted using 1 mL of PBS in the immediate 
postmortem period at 17 days after receipt of the pDCs. The obtained BAL samples 
were centrifuged. Differential cell counts were performed using cytocentrifuged BAL 
samples stained with May-Grünwald-Gìemsa. Lung tissues were also harvested for 
staining with hematoxylin and eosin (H&E) and periodic acid-Schiff stain (PAS). 
Mononuclear cells (MNCs) were prepared from lung tissues of mice that were isolated 
as described previously [27]. In brief, lung tissues were chopped using sterile scissors, 
and digested at 37 C in a water bath for 2 h in digestion buffer containing 1.5 mg/mL 
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collagenase A (type IA, Boehringer Mannheim, Mannheim, Germany), 0.02 mg/mL 
DNase I (type I, Boehringer Mannheim), and 0.75 mg/mL hyaluronidase (type I, Sigma). 
Digested lungs were filtered using a metal mesh to exclude cell pellets. The filtered 
digests were then washed three times with cRPMI 1640, followed by density gradient 
centrifugation to purify MNCs. These MNCs were cultured in the absence or presence 
of D. farinae for 48 h. The concentration of IFN-γ, IL-5 and IL-10 in the supernatants 
were determined by ELISA (Quantikine, R&D Systems Inc., Minneapolis, MN, USA) 
using the procedure described in the instruction manual. 

Effects of RSV infection on pDCs in vitro and in vivo 
In a different set of experiments, contDC and DfDC were infected with live RSV or 
HI-RSV [multiplicity of infection (MOI) of 1.0] for 2, 24 or 48 h. Quantitative real time 
PCR analysis of RSV L mRNA expression was performed using an ABI 7500 (Applied 
Biosystems) as described elsewhere.[25] IFN- was detected in the pDC-culture 
supernatants by ELISA (Quantikine). Four groups of pDCs (contDC-sham-Df, 
DfDC-sham-Df contDC-RSV-Df and DfDC-RSV-Df) were prepared from the spleen 
tissues of Control and Df mice. The contDC-sham-Df and DfDC-sham-Df groups were 
sham-infected with culture medium and the contDC-RSV-Df and DfDC-RSV-Df groups 
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were infected with live RSV for 24 h, at which time the viability of the RSV infected 
pDCs was >98%. Thereafter, these pDCs, at a concentration of 4 × 105 cells and in a 
volume of 100 L/mouse, were inoculated i.n. into four groups of 6-week-old female 
BALB/c mice on day 1. These mice were i.p. immunized twice (on days 1 and 14) with 
0.5 mg/mouse of Df allergen precipitated in aluminum hydroxide. All groups of mice 
were then i.n. challenged with 50 g/mL of the Df allergen once a day on days 14–16. 
Lung pathology, BAL and cytokine profiles in lung MNCs were determined as 
described above. HI-RSV failed to significantly regulate pDC function both in vitro and 
in vivo. 
 
Flow cytometric analysis of Tregs, myeloid DCs and IL-10 producing cells. 
Lung MNCs were prepared from the contDC-sham-Df, DfDC-sham-Df and the live 
RSV-infected contDC-RSV-Df and DfDC-RSV-Df groups of mice and were 
resuspended at 1 × 106 cells/mL. The cells were stained for expression of extracellular 
CD4 and CD25 and intracellular Foxp3 using the Mouse Treg FlowTM kit (Biolegend, 
San Diego, CA, USA). In a different set of experiments, the cells were stained for 
expression of extracellular CD4 and intracellular Foxp3 using PerCP-Cy5.5-labeled 
anti-murine CD4 antibodies and Alexa Fluor488-labeled anti-murine Foxp3 
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antibodies (BD Pharmingen, San Diego, CA, USA). For intracellular IL-10 staining, 
MNCs were cultured in the presence of 10 μg/mL Brefeldin A (Sigma, Buchs, 
Switzerland) for 4 h and were then stained with PE-labeled anti-murine IL-10 
antibodies (BD Pharmingen).[28] mDCs were identified as cells that stained positive 
with fluorescent antibodies against CD11c (Miltenyi Biotec) and CD11b (BD 
Pharmingen) but negative with antibodies against GR-1 (BD Pharmingen). For each 
analysis, staining with the appropriate isotype control mAb was also performed. The 
value of the control antibody was subtracted from that obtained for each antibody used. 




The results are expressed as the mean  SEM. Differences between groups were 
examined for statistical significance using repeated-measures analysis of variance with a 
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Results 
In vivo transfer of pDC-attenuated allergic airway inflammation in association 
with inhibition of Th1 and Th2 cytokines 
The effect of transfer of pDCs, isolated from control or Df mice, on allergic airway 
inflammation following challenge was examined. Mite allergen sensitized recipient 
mice harboring contDC (contDC-Df group) developed allergic airway inflammation 
characterized by peribronchovascular eosinophilic inflammation and goblet cell 
hyperplasia, as well as pulmonary eosinophilia determined by BAL. Transfer of DfDC 
significantly attenuated mite allergen-induced allergic airway inflammation (Figures 1A 
and B). The concentration of IFN-IL-5 and IL-10 in pulmonary MNCs isolated from 
these mice, and cultured in the absence or presence of the Derf allergen, was determined 
by ELISA (Figure 2). In comparison with contDC-PBS mice, contDC-Df mice produced 
significantly higher amounts of IFN- and IL-5. In the DfDC-Df mice, production of 
both IFN- and IL-5 was significantly inhibited compared to contDC-Df mice. 
Additionally, the concentration of IL-10, an immunoregulatory cytokine, was 
significantly enhanced in DfDC-Df mice compared to contDC-Df mice. Administration 
of the IL-10R monoclonal antibody before pDC transfer into DfDC-Df mice 
(DfDC-Df-IL-10R group) significantly increased the number of pulmonary 
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eosinophils (Figure 1) and the level of IFN- and IL-5 (Figure 2), while these 
parameters were still significantly lower compared to those in contDC-Df mice. In 
contrast to the effect of the IL-10R monoclonal antibody, administration of an isotype 
antibody into DfDC-Df mice failed to show significant effects on either the pathology 
or the cytokine profiles (data not shown). The combined data suggest that 
allergen-sensitized pDCs inhibited allergic airway inflammation and both Th1 and Th2 
immunity, at least partially via induction of IL-10. 
 
RSV replicated in pDCs and induced IFN- production 
To determine the susceptibility of splenic pDCs to RSV infection, ContDCs and DfDCs 
were exposed to either live RSV or HI-RSV (MOI of 1.0) for 2, 24 or 48 h. RSV L-gene 
mRNA expression was detected within 2 h (1020  .4 copies), peaked at 24 h (3420 
 .5 copies) and had decreased by 48 h (760  175.3 copies), as assessed by 
quantitative real time PCR. In accordance with these PCR results, live RSV infection 
induced IFN- production 24 h post-infection at a significantly higher level than 
HI-RSV infection (105.9  16.4 pg/mL for live RSV vs. 13.6  5.4 pg/mL for HI-RSV, 
p<0.05). The levels of IFN- were comparable between contDC and DfDC. Therefore, 
murine pDCs can be infected with live RSV and produce anti-viral IFN as described 




Regulation of the in vivo function of mite allergen-sensitized pDCs by RSV 
Live RSV- or sham-infected-pDCs were inoculated i.n. into mite allergen-sensitized 
donor mice followed by i.n. Df challenge. Representative photographs of the lung 
pathology as well as the BAL cell counts of these mice are shown in Figures 3A and B. 
In accordance with the earlier results, contDC-sham-Df mice developed allergic airway 
inflammation and DfDC-sham-Df mice showed ameliorated allergic airway 
inflammation. The lung pathology and different cellular components of BAL of 
contDC-RSV-Df mice were similar to those in contDC-sham-Df mice. In marked 
contrast to the DfDC-sham-Df mice, in which allergic airway inflammation was 
attenuated, DfDC-RSV-Df mice showed allergic airway inflammation similar to that in 
contDC-sham-Df mice. Cytokine profiles in lung MNCs revealed that the DfDC-sham 
Df mice showed significant reductions in IFN- and IL-5 and a significant increase in 
IL-10 compared to the contDC-sham-Df mice (Figure 4). ContDC-RSV-Df mice 
showed a significant increase in IFN- and a decrease in IL-10 but failed to alter IL-5 
production compared to contDC-sham-Df mice. Compared to contDC-sham-Df mice, 
the DfDC-RSV-Df mice demonstrated significant increases in IFN- and IL-5 but failed 
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to alter IL-10 production. To determine the mechanisms by which pDCs induce immune 
tolerance and the effects of RSV infection, the number of Treg, mDCs and the level of 
intracellular IL-10 in the lung tissues of recipient mice were determined by FACS 
analysis (Figure 5). Intranasal transfer of DfDC significantly increased the number of 
Treg and decreased that of mDCs compared to that of contDC. Furthermore, RSV 
infection significantly decreased Treg and increased mDCs in the lung tissue of 
DfDC-inoculated mice. Staining of intracellular IL-10 revealed that most CD4+IL-10+ T 
cells were Foxp3− (Figure 5C). The pDCs per se failed to produce IL-10 following Derf 
or RSV stimulation (data not shown). The combined data suggest that RSV infection 
may inhibit the immunoregulatory effects of pDCs through reductions in IL-10 and Treg 
and an increase in mDCs, thereby leading to enhancement of Th1 and Th2 immunity, 
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Discussion 
We have previously shown that RSV infection inhibits mDC function in the 
development of allergic airway inflammation.[19] The present study further 
characterized the effect of RSV infection on the other important DC subset, the pDCs. 
The results indicated that pDCs inhibit the development of allergic airway inflammation 
and that RSV infection interferes with the pDC-inhibitory effect via inhibition of 
immunotolerance wherein Treg play a partial but critical role. Thus, RSV may 
differently regulate DC function in the development of allergic airway inflammation; 
RSV ameliorates or exacerbates allergic airway inflammation by regulation of mDCs or 
pDCs, respectively. 
Intranasal inoculation of mite allergen-pulsed murine bone marrow-derived mDCs 
enhances allergic airway inflammation and IL-5 and IFN- production in lung draining 
lymph nodes, indicating that mDCs promote allergy.[18,19] In contrast, depletion of 
pDCs during allergen inhalation resulted in the enhancement of Th2-mediated allergic 
airway inflammation. Furthermore, adoptive transfer of pDCs prior to allergen 
sensitization prevented allergic airway inflammation and suppressed the generation of 
effector T cells induced by mDCs.[23] These data suggest that pDCs have a protective 
role against allergy. In the present study, splenic pDCs isolated from mite 
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allergen-sensitized mice also inhibited allergic airway inflammation. Our preliminary 
unpublished observations showed that; i) pDCs isolated from PBS-challenged 
Derf-alum sensitized mice failed to cause significant effects in recipient mice, ii) pDCs 
isolated from Derf-sensitized and challenged mice failed to cause significant effects in 
Aspergillus fumigatus allergen-sensitized and challenged recipient mice and iii) in vitro 
sensitization of control pDCs with Derf allergen could not show similar effects to those 
observed with pDCs from allergen sensitized and challenged mice. These observations 
confirmed that the immunological effects of pDCs observed in the present study 
required systemic allergen sensitization along with local allergen challenge and that they 
were allergen specific. The cytokine profile of lung MNCs demonstrated that mite 
allergen-sensitized pDCs inhibit IL-5 and IFN- production but increase IL-10 
production. In addition, neutralization of IL-10 in the recipient lung significantly, but 
incompletely blocked the inhibitory effects of pDCs on the development of allergic 
airway inflammation. Since IL-10 has been linked to the development of Treg, which 
can be induced by pDCs [32], we had originally expected that a pDC-induced increase 
in Treg might be the source of the IL-10. Indeed, flow cytometric analysis revealed that 
intranasal transfer of mite allergen-sensitized pDCs enhanced the number of Treg in the 
lung tissues of recipient mice. However, unexpectedly, intracellular IL-10 staining 
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demonstrated that CD4+Foxp3−, but not CD4+Foxp3+ cells were the source of the IL-10. 
In accordance with these results, adoptive transfer of Treg suppressed allergic 
inflammation via a mechanism dependent upon IL-10, wherein the IL-10 was induced 
by bystander CD4+ cells rather than by the Treg themselves.[33] Although a direct 
association between Treg and IL-10 is yet to be determined these results suggest that 
one of the mechanisms by which pDCs inhibit allergic airway inflammation appears to 
be by the induction of both Treg and IL-10. 
Few studies have evaluated the interaction between RSV infection and allergen 
sensitization at the level of pDCs. In this study, once they were infected with live RSV, 
the pDCs lost their ability to induce Treg and IL-10 in the lung tissues of recipient mice 
and thus lost their ability to inhibit development of allergic airway inflammation. 
However, neutralization of IL-10 in the recipient lung significantly, but incompletely, 
restored the inhibitory effects of pDCs in allergic airway inflammation. Although the 
number of pulmonary Treg significantly decreased in RSV-infected DfDC-transferred 
mice compared to that in sham-infected DfDC-transferred mice, it was still significantly 
higher than that in sham-infected, control DfDC-transferred mice. Nonetheless, both 
Th1 and Th2 cytokine production was significantly enhanced in lung tissue of 
RSV-infected DfDC-transferred mice compared to sham-infected control 
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DfDC-transferred mice. Collectively, these results suggest that RSV infection of pDCs 
not only interferes with Treg induction but also enhances adaptive immunity through 
another pathway. Our search for a second pathway focused on the regulation of mDCs 
by pDCs. It is known that, following viral infection pDCs produce IFN-which is a 
growth and maturation factor for mDCs.[32,34-36] Furthermore, pDCs have been 
reported to suppress eosinophilic inflammation by inhibiting the function of mDCs.[37] 
Intranasal inoculation of pDCs significantly decreased the number of mDCs in recipient 
mice, but significantly increased mDCs following RSV infection. Thus, the innate 
IFN- response against RSV by pDCs might promote mDC proliferation resulting in 
the enhancement of adaptive immunity as previously described for the adjuvant action 
of poly IC.[38] 
In conclusion, these results indicate that pDCs are potent inhibitors of the 
development of allergic airway inflammation and that these inhibitory effects are 
reduced following RSV infection. The present study indicates that the interaction 
between pDCs and RSV may modulate pDC-effects on immunity and that these 
pDC-effects include induction of IL-10, Treg and a decrease in the number of mDCs. 
These effects of pDCs may synergize with other as yet unknown cellular and molecular 
mechanisms to modulate immunity. In addition, the present study not only sheds light 
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on the mechanism of viral infection and allergy, but also suggests a new therapeutic 
modality. Therapies targeting the function of pDCs may be useful for generation of a 
vaccine against the development of asthma. 
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Figure legends 
Figure 1. Lung pathology and differential cell counts in bronchoalveolar lavage of 
mice inoculated with pDCs. Mice were inoculated with splenic pDCs 
(CD3−CD19−CD11b−CD49b−B220+CD11c+PDCA1+) and, following sacrifice, lung 
tissues were obtained and stained with H&E and PAS. Representative photographs of 
each group (n=8, from three independent experiments, each experimental group 
consisted of 2–3 mice) are shown (A). Original magnification 400. Differential cell 
counts in BAL (B). The bars represent the mean  SEM (n=8 for each group). 
Differences between groups were examined for statistical significance using 
repeated-measures analysis of variance with a Bonferroni multiple comparison test. 
**p<0.01 and *p<0.05 vs. contDC-PBS. ††p<0.01 and †p<0.05 vs. contDC-Df. #p<0.05 
vs. DfDC-Df. 
 
Figure 2. Cytokine profiles of lung tissue of pDC-inoculated mice. Pulmonary 
MNCs were isolated from the indicated five groups of BALB/c mice inoculated with 
pDCs. These MNCs were cultured in the absence or presence of the Derf allergen, and 
the concentration of IFN-γ, IL-5 and IL-10 was determined by ELISA. The bars 
represent the mean (n=8 for each group)  SEM. Differences between groups were 
 Tsuchida et al. revised MS No.: 201009016 PAGE 24 
 
examined for statistical significance using repeated-measures analysis of variance with a 
Bonferroni multiple comparison test. **p<0.01 and *p<0.05 vs. contDC-PBS. ††p<0.01 
and †p<0.05 vs. contDC-Df. #p<0.05 vs. DfDC-Df. 
 
Figure 3. Lung pathology and differential cell counts in bronchoalveolar lavage of 
mice inoculated with RSV-infected pDCs. Mice were inoculated with RSV-infected 
pDCs. Lung pathology was determined microscopically (A) and BAL was analyzed (B) 
as described in the legend to Figure 1. The bars represent the mean  SEM (n=8 for 
each group). Differences between groups were examined for statistical significance 
using repeated-measures analysis of variance with a Bonferroni multiple comparison 
test. **p<0.01 and *p<0.05 vs. contDC-sham-Df. ††p<0.01 and †p<0.05 vs. 
DfDC-sham-Df. 
 
Figure 4. Cytokine profiles of lung tissue of RSV-infected pDC-inoculated mice. 
Pulmonary MNCs were isolated from the indicated four groups of BALB/c mice 
inoculated with RSV- or sham-infected pDCs. These MNCs were cultured in the 
absence or presence of Derf allergen, and the concentration of IFN-γ, IL-5 and IL-10 
was determined by ELISA. The bars represent the mean (n=8 for each group)  SEM. 
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Differences between groups were examined for statistical significance using 
repeated-measures analysis of variance with a Bonferroni multiple comparison test. 
**p<0.01 and *p<0.05 vs. contDC-sham-Df. ††p<0.01 and †p<0.05 vs. DfDC-sham-Df. 
 
Figure 5. Number of CD4+CD25+Foxp3+ T cells, mDCs and IL-10+ populations in 
lung. Pulmonary MNCs were isolated from the indicated four groups of BALB/c mice 
that had been inoculated with pDCs. The number of CD4+CD25+Foxp3+ T cells (upper) 
and CD11c+CD11b+GR-1– mDCs (middle), as well as the number of IL-10+ cells in 
CD4+Foxp3− and CD4+Foxp3+ cells (lower) in the lung was then assessed. The bars 
represent the mean (n=8 for each group)  SEM. Differences between groups were 
examined for statistical significance using repeated-measures analysis of variance with a 
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